Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer

NCT00126633 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: cisplatin
DRUG: gemcitabine hydrochloride

Sponsor

University of California, San Francisco

Collaborators

[object Object]